Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Benign Hematology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Benign Hematology

Journal Scan / Research · October 09, 2022

Achieving Higher Efficacy Without Compromising Safety With Factor XI Inhibitors vs LMWH for Preventing VTE in Major Orthopedic Surgery

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Journal of Thrombosis and Haemostasis (JTH)
Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery - Systematic Review and Meta-Analysis
J. Thromb. Haemost. 2022 Sep 21;[EPub Ahead of Print], J Presume, J Ferreira, R Ribeiras, M Mendes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading